<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/935B2919-2093-4FB9-A5D4-59F746D5235A"><gtr:id>935B2919-2093-4FB9-A5D4-59F746D5235A</gtr:id><gtr:name>University of California, Irvine</gtr:name><gtr:address><gtr:line1>UCI</gtr:line1><gtr:postCode>92697</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A82ABD22-95F9-48B1-9861-614E0B30B2EB"><gtr:id>A82ABD22-95F9-48B1-9861-614E0B30B2EB</gtr:id><gtr:name>University of Urbino</gtr:name><gtr:address><gtr:line1>Universita degli Studi di Urbino</gtr:line1><gtr:line2>via Saffi 2</gtr:line2><gtr:line4>Urbino</gtr:line4><gtr:postCode>I-61029</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DF0020F8-9212-4670-ADC0-CBDFF5B93548"><gtr:id>DF0020F8-9212-4670-ADC0-CBDFF5B93548</gtr:id><gtr:name>GlaxoSmithKline</gtr:name><gtr:address><gtr:line1>Stockley Park West</gtr:line1><gtr:line4>Uxbridge</gtr:line4><gtr:postCode>UB11 1BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A5972A27-23A6-4BFF-9546-DB6E3D001BB9"><gtr:id>A5972A27-23A6-4BFF-9546-DB6E3D001BB9</gtr:id><gtr:name>Vernalis Research Ltd</gtr:name><gtr:address><gtr:line1>Oakdene Court</gtr:line1><gtr:line2>613 Reading Road, Winnersh</gtr:line2><gtr:line4>Wokingham</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>RG41 5UA</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/22F1A3BE-CB81-4257-B3DD-436998402B87"><gtr:id>22F1A3BE-CB81-4257-B3DD-436998402B87</gtr:id><gtr:name>Parma Hospital</gtr:name><gtr:address><gtr:line1>Azienda Ospedaliera di Parma</gtr:line1><gtr:line2>Via Gramsci 14</gtr:line2><gtr:line4>Parma</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9A22541F-DA58-481E-8D0C-C4BCF4EA030E"><gtr:id>9A22541F-DA58-481E-8D0C-C4BCF4EA030E</gtr:id><gtr:name>EMBL - European Bioinformatics Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB10 1SD</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2A2990B1-E1E1-4888-8848-7C256C3A3B43"><gtr:id>2A2990B1-E1E1-4888-8848-7C256C3A3B43</gtr:id><gtr:firstName>Adrian</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Mulholland</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FG007705%2F1"><gtr:id>63B0BF34-5E4C-46CA-8682-EFCD3C2CE5E9</gtr:id><gtr:title>Computational biochemistry: predictive modelling for biology and medicine</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>EP/G007705/1</gtr:grantReference><gtr:abstractText>All of biology - life itself - depends on enzymes. Enzymes are large, natural molecules that allow specific biochemical reactions to take place quickly. As yet we do not understand what it is that makes them such good natural catalysts. There are many reasons for studying enzymes and the reactions they catalyse: many drugs are enzyme inhibitors (they stop specific enzymes from working), so better understanding of enzymes will help in the design of new drugs. It should also help understand and predict the effects of genetic variation, for example in understanding why some people may benefit from a particular drug, or may be at risk from a disease. Enzymes are also very good and environmentally friendly catalysts - knowing how they function should help in the design and development of new 'green' catalysts for industrial applications. Enzymes also show great promise as 'molecular machines' in the emerging field of nanotechnology. We will develop and apply advanced computer modelling methods , in collaboration with experimental biochemistry, to analyse in detail how enzymes work. We will study enzymes that are targets for designing drugs for the treatment of pain and anxiety, and study how drugs are broken down by enzymes in the body. We will develop new modelling methods, capable of dealing accurately with these large and complex systems, and the chemical reactions they catalyse. We will bring together state-of-the-art computer software and hardware, and new theoretical methods, to achieve unprecedented accuracy for modelling enzymes. These modelling methods promise to add an extra dimension to studying enzyme reactions - e.g. making molecular 'movies' of how enzymes work. We will also use the methods we develop to predict how strongly potential drugs bind to their protein targets. The methods we will develop and use are based on fundamental quantum mechanics, so will be better than current approximate techniques. Current methods for predicting how strongly different drugs bind to proteins are efficient, but lack reliability because they fail to capture the essential physics. Quantum mechanics provides a physically accurate representation of the interactions, but until now these methods have been too computationally intensive for practical use. We will base our developments on methods that can accurately model chemical reactions of small molecules, combined with techniques for modelling protein structure and dynamics, and extend these to study enzymes and their reactions. We will make use of the great power provided by the latest 'multi-core' computer chips. Altogether, this will require several ground-breaking developments, which we are well placed to carry out. We will develop and apply new methods that can calculate how reactions happen in enzymes, describing the energies of breaking and forming chemical bonds accurately and analyse how reaction is affected by protein dynamics. This work will be carried out in collaboration with experiments, with project partners in academia and industry, in the UK and abroad. We will make predictions and compare with experiments on the same enzymes to test our theoretical methods. This will involve the transfer and exchange of methods, data, ideas and researchers between experimental and modelling groups, in new and existing collaborations. The methods we develop and the results we obtain will be made widely available (e.g. via the web), and should be very useful to biologists, biochemists, drug designers and other researchers working on enzymes. We will extend these high-level methods to new areas of biology, to provide new tools for studying protein structure. The results should provide new and exciting insight into how enzymes function, and promise to make a major contribution to the development of new drugs.</gtr:abstractText><gtr:fund><gtr:end>2014-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2008-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1137045</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>13528180</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Synthetic Biology Research Centre. BrisSynBio: Bristol Centre for Synthetic Biology</gtr:description><gtr:end>2019-07-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/L01386X/1</gtr:fundingRef><gtr:id>4288827C-FB4B-4A2B-A8D5-E7A247DE4FD5</gtr:id><gtr:outcomeId>54568e4e0f90d2.05724463</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3038984</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC sLoLa: Innovative Routes to Monoterpene Hydrocarbons and Their High Value Derivatives</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/M000354/1</gtr:fundingRef><gtr:id>D23E341E-D656-41D7-A209-52C032EEB2C3</gtr:id><gtr:outcomeId>54568f0107b951.25851904</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>146027</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Tools and Techniques: Computational tools for enzyme engineering: bridging the gap between enzymologists and expert simulation</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/L018756/1</gtr:fundingRef><gtr:id>FFF8F601-5C47-48CF-97D8-DB8D17719924</gtr:id><gtr:outcomeId>54568d37229182.28823814</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>188950</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>E/EP/G007705/1</gtr:fundingRef><gtr:id>7ADA36A8-A559-402F-A15D-AC85172A6D33</gtr:id><gtr:outcomeId>5ed84c5a5ed84c78</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The overall aim of my Fellowship was the development and application of computational molecular simulation methods for biological problems. Combined quantum mechanics/molecular mechanics (QM/MM) methods are a particular focus. Aims include modelling mechanisms of enzyme catalysis and studies of ligand binding. The Fellowship has been a step change in my career. It facilitated my promotion to a Chair. It has significantly broadened the range, scope and impact of my work. Method development, and particularly testing of simulations against experiment, has helped to define reliable and generally useful protocols and parameters which will be widely applicable. In addition to the need for accurate methods, the findings emphasise the importance of accounting for the dynamic and conformational complexity of biomolecules. These methods are finding increasingly wide application in biology, expanding beyond the 'traditional' investigations of enzyme biochemistry into areas such as drug design. The objectives were in four interweaved strands; progress in each area is summarized below. These included development of methods for modelling biomolecular mechanisms; modelling mechanisms of drug metabolism; methods for protein-ligand binding; and new areas of application of QM/MM methods. Throughout, comparison with experiment has been important (examples include fluorocitrate synthesis, alkene oxidation, epoxide ring opening, enzyme-inhibitor complex structures, kinetic isotope effects (KIEs), spectroscopic properties and covalent inhibitor reactivity). We have shown that useful modelling relies both on accurate methods and also, crucially, on taking into account protein dynamics. This work has included high level QM/MM (e.g. the first applications of SCS-MP2 QM/MM methods), in combination with molecular dynamics and Monte Carlo simulations. A broad aim is to disseminate QM/MM methods, and develop collaborations particularly with experimental groups. Another aim has been to use advanced computational technology. While the collaboration with Clearspeed unfortunately ceased because of that company's financial situation, I have continued software development efforts (e.g. in a separate current EPSRC project, EP/I030395/1) for efficient use of HPC resources, multicore processors and graphics processing units (GPUs), which offer tremendous potential increases in speed and thus the scale of problems that can be tackled. 1. Biomolecular mechanisms: Analysis of stereospecificity determinants in 'lethal synthesis' of fluorocitrate by ab initio QM/MM (van der Kamp et al. Angewandte VIP 2011); antibiotic breakdown in a Class A ?-lactamase (Hermann et al. JPCA 2009); carboxypeptidase A; chitinase (Jitonnom et al. Biochemistry 2011); analysis of catalysis in chorismate mutase (Ranaghan et al. OBC 2011); implementation of the nudged elastic band method for reaction pathways and testing QM/MM methods (e.g. van der Kamp et al. JPCB 2010); GPUs for protein molecular dynamics simulations (Woods et al. Biochemistry, submitted), and enhanced sampling in QM/MM (Shaw et al. JACS submitted); development of a model for KIEs in enzymes involving quantum tunnelling (Glowacki et al. Nature Chem. 2012). 2. Mechanisms of drug metabolism: e.g., QM/MM studies of cytochrome P450 enzymes including human isoforms 2C9, 3A4, 2B4 and complexes with warfarin (Lonsdale et al JACS 2011); analysis of determinants of metabolism of dextromethorphan in 2D6 (Olah et al. PNAS 2011); modelling reactions of epoxide hydrolase, involved in Phase 2 drug metabolism (Lonsdale et al. Biochemistry 2012), identifying origins of observed specificity. 3. QM/MM free energy calculations and new methods for protein-ligand binding: ab initio QM/MM thermodynamic integration free energy calculations (e.g. binding in neuraminidase complexes, Shaw et al. JACS, submitted); testing QM/MM models by free energy calculations (Shaw et al. JPCL 2010); development of a new 'water-swap' reaction coordinate for calculation of absolute protein-ligand binding free energies (Woods et al. J. Chem. Phys. 2011); importance of dispersion effects and dynamics in alkene binding and reactivity in P450s (Lonsdale et al JPCL 2010, JPCB 2010); modelling of inhibitor complexes of the drug target fatty acid amide hydrolase (FAAH). 4. New applications of QM/MM methods e.g. QM/MM calculations combined with optimal control theory to design laser pulses for specific excitation of substrate vibrational quantum states relevant to reaction in aromatic amine dehydrogenase (AADH) (Ren et al. Chem. Phys. Lett. 2010); development of parameters for QM/MM modelling of nucleic acids (Pentikainen et al JCTC 2009); QM/MM modelling of protein splicing (Mujika et al. JPCB 2009, OBC 2012); Our QM/MM prediction of the structure of FAAH complexes was verified by crystallography (highlighted in RSC Chemistry World 2010); analysis of factors responsible for the observed pharmacokinetics of FAAH carbamate inhibitors (Lodola et al. Chem Comm 2011); multivariate analysis of reaction in FAAH (Lodola et al. JCTC 2010). I have published 27 peer-reviewed papers and 5 book chapters during my Fellowship, and organized conferences such as Computational Molecular Science 2010. I am Chair of the new EPSRC supported collaborative computational project in biomolecular simulation, CCP-BioSim. The Flagship Project is on developing multiscale modelling methods. I have collaborated with groups as planned e.g. in Parma (on FAAH) and Bristol (on ?-lactamase structure and dynamics) and established new collaborations with experimental groups e.g. in Kansas, Leicester, Leeds, UIUC, Michigan, and Chulalongkorn, with funding from NIH(US), Thai Government and EPSRC, including in HPC software development. Industrial links include a studentship with Neusentis, building on work with Pfizer, and paid consultancy with GSK and Shire Pharmaceuticals. Dissemination to experimentalists has involved practical guides (e.g. Lonsdale et al. Chem. Soc. Rev. 2012) and workshops e.g. on QM/MM via CCP-BioSim, and teaching on FEBS and Biochemical Society courses, and numerous conference presentations and research seminars.</gtr:description><gtr:firstYearOfImpact>2014</gtr:firstYearOfImpact><gtr:id>F3061EAD-7B9D-4B41-BEF3-DC9EBDABAEAF</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56e0c1b1c36e65.00631506</gtr:outcomeId><gtr:sector>Chemicals,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The overall aim of my Leadership Fellowship was the development and application of computational molecular simulation methods for biological problems. Combined quantum mechanics/molecular mechanics (QM/MM) methods are a particular focus. Aims include modelling mechanisms of enzyme catalysis and studies of ligand binding. The Fellowship has been a step change in my career. It facilitated my promotion to a Chair. It has significantly broadened the range, scope and impact of my work. Method development, and particularly testing of simulations against experiment, has helped to define reliable and generally useful protocols and parameters which will be widely applicable. In addition to the need for accurate methods, the findings emphasise the importance of accounting for the dynamic and conformational complexity of biomolecules. These methods are finding increasingly wide application in biology, expanding beyond the 'traditional' investigations of enzyme biochemistry into areas such as drug design. The objectives were in four interweaved strands; progress in each area is summarized below. These included development of methods for modelling biomolecular mechanisms; modelling mechanisms of drug metabolism; methods for protein-ligand binding; and new areas of application of QM/MM methods. Throughout, comparison with experiment has been important (examples include fluorocitrate synthesis, alkene oxidation, epoxide ring opening, enzyme-inhibitor complex structures, kinetic isotope effects (KIEs), spectroscopic properties and covalent inhibitor reactivity). We have shown that useful modelling relies both on accurate methods and also, crucially, on taking into account protein dynamics. This work has included high level QM/MM (e.g. the first applications of SCS-MP2 QM/MM methods), in combination with molecular dynamics and Monte Carlo simulations. A broad aim is to disseminate QM/MM methods, and develop collaborations particularly with experimental groups. Another aim has been to use advanced computational technology. While the collaboration with Clearspeed unfortunately ceased because of that company's financial situation, I have continued software development efforts (e.g. in a separate current EPSRC project, EP/I030395/1) for efficient use of HPC resources, multicore processors and graphics processing units (GPUs), which offer tremendous potential increases in speed and thus the scale of problems that can be tackled.
1. Biomolecular mechanisms: Analysis of stereospecificity determinants in 'lethal synthesis' of fluorocitrate by ab initio QM/MM (van der Kamp et al. Angewandte VIP 2011); antibiotic breakdown in a Class A ?-lactamase (Hermann et al. JPCA 2009); carboxypeptidase A; chitinase (Jitonnom et al. Biochemistry 2011); analysis of catalysis in chorismate mutase (Ranaghan et al. OBC 2011); implementation of the nudged elastic band method for reaction pathways and testing QM/MM methods (e.g. van der Kamp et al. JPCB 2010); GPUs for protein molecular dynamics simulations (Woods et al. Biochemistry, submitted), and enhanced sampling in QM/MM (Shaw et al. JACS submitted); development of a model for KIEs in enzymes involving quantum tunnelling (Glowacki et al. Nature Chem. 2012). 2. Mechanisms of drug metabolism: e.g., QM/MM studies of cytochrome P450 enzymes including human isoforms 2C9, 3A4, 2B4 and complexes with warfarin (Lonsdale et al JACS 2011); analysis of determinants of metabolism of dextromethorphan in 2D6 (Olah et al. PNAS 2011); modelling reactions of epoxide hydrolase, involved in Phase 2 drug metabolism (Lonsdale et al. Biochemistry 2012), identifying origins of observed specificity. 3. QM/MM free energy calculations and new methods for protein-ligand binding: ab initio QM/MM thermodynamic integration free energy calculations (e.g. binding in neuraminidase complexes, Shaw et al. JACS, submitted); testing QM/MM models by free energy calculations (Shaw et al. JPCL 2010); development of a new 'water-swap' reaction coordinate for calculation of absolute protein-ligand binding free energies (Woods et al. J. Chem. Phys. 2011); importance of dispersion effects and dynamics in alkene binding and reactivity in P450s (Lonsdale et al JPCL 2010, JPCB 2010); modelling of inhibitor complexes of the drug target fatty acid amide hydrolase (FAAH). 4. New applications of QM/MM methods e.g. QM/MM calculations combined with optimal control theory to design laser pulses for specific excitation of substrate vibrational quantum states relevant to reaction in aromatic amine dehydrogenase (AADH) (Ren et al. Chem. Phys. Lett. 2010); development of parameters for QM/MM modelling of nucleic acids (Pentikainen et al JCTC 2009); QM/MM modelling of protein splicing (Mujika et al. JPCB 2009, OBC 2012); Our QM/MM prediction of the structure of FAAH complexes was verified by crystallography (highlighted in RSC Chemistry World 2010); analysis of factors responsible for the observed pharmacokinetics of FAAH carbamate inhibitors (Lodola et al. Chem Comm 2011); multivariate analysis of reaction in FAAH (Lodola et al. JCTC 2010). I have published 27 peer-reviewed papers and 5 book chapters during my Fellowship, and organized conferences such as Computational Molecular Science 2010. I am Chair of the new EPSRC supported collaborative computational project in biomolecular simulation, CCP-BioSim. The Flagship Project is on developing multiscale modelling methods. I have collaborated with groups as planned e.g. in Parma (on FAAH) and Bristol (on ?-lactamase structure and dynamics) and established new collaborations with experimental groups e.g. in Kansas, Leicester, Leeds, UIUC, Michigan, and Chulalongkorn, with funding from NIH(US), Thai Government and EPSRC, including in HPC software development. Industrial links include a studentship with Neusentis, building on work with Pfizer, and paid consultancy with GSK and Shire Pharmaceuticals. Dissemination to experimentalists has involved practical guides (e.g. Lonsdale et al. Chem. Soc. Rev. 2012) and workshops e.g. on QM/MM via CCP-BioSim, and teaching on FEBS and Biochemical Society courses, and numerous conference presentations and research seminars.</gtr:description><gtr:exploitationPathways>CCP-BioSim will provide an excellent avenue for disseminating the methods developed here to ensure their uptake and use by the wider research community. See www.ccpbiosim.ac.uk and HECBioSim.ac.uk Software tools will be useful to researchers in industry and academia.</gtr:exploitationPathways><gtr:id>400D8449-A078-45F9-ACBA-0054D2E79CBA</gtr:id><gtr:outcomeId>56e0c132be8768.40596072</gtr:outcomeId><gtr:sectors><gtr:sector>Chemicals,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>https://sites.google.com/site/mulhollandresearchgroup/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>2010.1 release of Sire molecular simulation framework. Main enhancement was the development and inclusion of code to perform waterswap absolute binding free energy calculations. This was the first release of software capable of performing these kinds of calculation.</gtr:description><gtr:id>72C3A309-DD2B-4D4E-9BE8-102F0FD4D8E9</gtr:id><gtr:impact>This version of the code was used to run the simulations in &amp;quot;A water-swap reaction coordinate for the calculation of absolute
protein-ligand binding free energies&amp;quot;, Woods, CJ, Malaisree, M, Hannongbua, S &amp;amp; Mulholland, AJ (2011) Journal of Chemical Physics, vol 134, no. 5, 054114 DOI:10.1063/1.3519057, the first application of the WaterSwap method. The accurate prediction of absolute protein-ligand binding free energies is one of the grand challenge problems of computational science. Binding free energy measures the strength of binding between a ligand and a protein, and an algorithm that would allow its accurate prediction would be a powerful tool for rational drug design. Here we present the development of a new method that allows for the absolute binding free energy of a protein-ligand complex to be calculated from first principles, using a single simulation. Our method involves the use of a novel reaction coordinate that swaps a ligand bound to a protein with an equivalent volume of bulk water. This water-swap reaction coordinate is built using an identity constraint, which identifies a cluster of water molecules from bulk water that occupies the same volume as the ligand in the protein active site. A dual topology algorithm is then used to swap the ligand from the active site with the identified water cluster from bulk water. The free energy is then calculated using replica exchange thermodynamic integration. This returns the free energy change of simultaneously transferring the ligand to bulk water, as an equivalent volume of bulk water is transferred back to the protein active site. This, directly, is the absolute binding free energy. It should be noted that while this reaction coordinate models the binding process directly, an accurate force field and sufficient sampling are still required to allow for the binding free energy to be predicted correctly. In this paper we present the details and development of this method, and demonstrate how the potential of mean force along the water-swap coordinate can be improved by calibrating the soft-core Coulomb and Lennard-Jones parameters used for the dual topology calculation. The optimal parameters were applied to calculations of protein-ligand binding free energies of a neuraminidase inhibitor (oseltamivir), with these results compared to experiment. These results demonstrate that the water-swap coordinate provides a viable and potentially powerful new route for the prediction of protein-ligand binding free energies.</gtr:impact><gtr:outcomeId>54628ddb54dbf8.19533391</gtr:outcomeId><gtr:title>Sire 2010.1</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://www.siremol.org/Sire/Home.html</gtr:url><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2EA99031-B8E3-4D9C-8BDF-5042A1DD2CDF</gtr:id><gtr:title>&amp;quot;Lethal synthesis&amp;quot; of fluorocitrate by citrate synthase explained through QM/MM modeling.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fddacbc6ce8fb11a5bf667abf1aa4721"><gtr:id>fddacbc6ce8fb11a5bf667abf1aa4721</gtr:id><gtr:otherNames>van der Kamp MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>54561517e26414.45903215</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0025735-B3C7-4604-BFCA-4FA69DC6B7A4</gtr:id><gtr:title>Lennard-Jones Parameters for B3LYP/CHARMM27 QM/MM Modeling of Nucleic Acid Bases.</gtr:title><gtr:parentPublicationTitle>Journal of chemical theory and computation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41964e92d70847b0f1c1293281c9458d"><gtr:id>41964e92d70847b0f1c1293281c9458d</gtr:id><gtr:otherNames>Pentik?inen U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1549-9618</gtr:issn><gtr:outcomeId>54561c773ea889.39430938</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B1C9FAF-A4BD-491A-B27E-295CE3007DD0</gtr:id><gtr:title>QM/MM simulations as an assay for carbapenemase activity in class A ?-lactamases.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89c5f635bc37f4387335cd425afa7aa8"><gtr:id>89c5f635bc37f4387335cd425afa7aa8</gtr:id><gtr:otherNames>Chudyk EI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>545615151be1b3.50133562</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3092297B-E2EE-45E1-A699-1BD11E3895FA</gtr:id><gtr:title>Rapid Estimation of Catalytic Efficiency by Cumulative Atomic Multipole Moments: Application to Ketosteroid Isomerase Mutants.</gtr:title><gtr:parentPublicationTitle>Journal of chemical theory and computation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75d3af4967d6051eadb0b7687b2978ed"><gtr:id>75d3af4967d6051eadb0b7687b2978ed</gtr:id><gtr:otherNames>Beker W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1549-9618</gtr:issn><gtr:outcomeId>58c2e765de0f53.03515035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>498E04BE-C8EF-4062-B2D9-A9D9A218EE10</gtr:id><gtr:title>L718Q mutant EGFR escapes covalent inhibition by stabilizing a non-reactive conformation of the lung cancer drug osimertinib</gtr:title><gtr:parentPublicationTitle>Chemical Science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/955d04572f4dedb95434f7743c6a7d2e"><gtr:id>955d04572f4dedb95434f7743c6a7d2e</gtr:id><gtr:otherNames>Callegari D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5a9959e4b5e3c3.41928893</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D91830EE-92A9-4C83-AEDE-42BAC92EA6F5</gtr:id><gtr:title>QM/MM simulations indicate that Asp185 is the likely catalytic base in the enzymatic reaction of HIV-1 reverse transcriptase</gtr:title><gtr:parentPublicationTitle>MedChemComm</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f57bb58b628193f80062706dcd5c20aa"><gtr:id>f57bb58b628193f80062706dcd5c20aa</gtr:id><gtr:otherNames>Rungrotmongkol T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545618de1b38d4.64994158</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9645DDA2-2482-4284-83E0-50A2DF9FEA46</gtr:id><gtr:title>Analysis of polarization in QM/MM modelling of biologically relevant hydrogen bonds.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f25dca82781f50217553cb15ce363cb"><gtr:id>9f25dca82781f50217553cb15ce363cb</gtr:id><gtr:otherNames>Senthilkumar K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn><gtr:outcomeId>585d4afe7bbaf5.04782719</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E64156B-A50E-4741-AA8A-DA93BD298EAF</gtr:id><gtr:title>Combined quantum mechanics/molecular mechanics (QM/MM) simulations for protein-ligand complexes: free energies of binding of water molecules in influenza neuraminidase.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry. B</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cfc092ebabd10e7bab211677c638b22"><gtr:id>0cfc092ebabd10e7bab211677c638b22</gtr:id><gtr:otherNames>Woods CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1520-5207</gtr:issn><gtr:outcomeId>54561c75a02741.38139476</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6389EEE-2E0E-4C9F-9FE9-7C14E6A70E61</gtr:id><gtr:title>A practical guide to modelling enzyme-catalysed reactions.</gtr:title><gtr:parentPublicationTitle>Chemical Society reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0306-0012</gtr:issn><gtr:outcomeId>54561517bc6e20.92794569</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7B4A68B-082E-476D-8294-B995CF0A7999</gtr:id><gtr:title>Inclusion of Dispersion Effects Significantly Improves Accuracy of Calculated Reaction Barriers for Cytochrome P450 Catalyzed Reactions</gtr:title><gtr:parentPublicationTitle>The Journal of Physical Chemistry Letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>54561c76e2bda7.49676960</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D450A10-7159-485D-B9E5-6DE46DA5895E</gtr:id><gtr:title>Compatibility of Quantum Chemical Methods and Empirical (MM) Water Models in Quantum Mechanics/Molecular Mechanics Liquid Water Simulations</gtr:title><gtr:parentPublicationTitle>The Journal of Physical Chemistry Letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c73245430cab7e5e2010f9b8cb7b6eb1"><gtr:id>c73245430cab7e5e2010f9b8cb7b6eb1</gtr:id><gtr:otherNames>Shaw K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>doi_53d01a01a4030bc6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>872A3B16-C2B2-45F5-9AF2-08141C82239A</gtr:id><gtr:title>Testing high-level QM/MM methods for modeling enzyme reactions: acetyl-CoA deprotonation in citrate synthase.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry. B</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fddacbc6ce8fb11a5bf667abf1aa4721"><gtr:id>fddacbc6ce8fb11a5bf667abf1aa4721</gtr:id><gtr:otherNames>van der Kamp MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1520-5207</gtr:issn><gtr:outcomeId>5456165c947437.28131254</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14A49573-A9A8-4B26-B313-FFF58268DC5E</gtr:id><gtr:title>Determinants of reactivity and selectivity in soluble epoxide hydrolase from quantum mechanics/molecular mechanics modeling.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>54561517990472.67982979</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C64D770B-5F49-4CD5-AC19-DE711FEA5CD9</gtr:id><gtr:title>A multiscale approach to modelling drug metabolism by membrane-bound cytochrome P450 enzymes.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>545615153fe9b4.28497639</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07105653-70B2-47A1-9FC3-A48C5478CD78</gtr:id><gtr:title>Nonempirical energetic analysis of reactivity and covalent inhibition of fatty acid amide hydrolase.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry. B</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89c5f635bc37f4387335cd425afa7aa8"><gtr:id>89c5f635bc37f4387335cd425afa7aa8</gtr:id><gtr:otherNames>Chudyk EI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1520-5207</gtr:issn><gtr:outcomeId>5456151644e867.85836019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E359860F-213D-4A8B-898A-2F8C153C815A</gtr:id><gtr:title>In pursuit of an accurate spatial and temporal model of biomolecules at the atomistic level: a perspective on computer simulation.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f516dd0f5d3b9fb06a2aa733c8ecdd2b"><gtr:id>f516dd0f5d3b9fb06a2aa733c8ecdd2b</gtr:id><gtr:otherNames>Gray A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>doi_55f974974b025f44</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1CFA1A2-FEAD-4FBE-AE0F-61FEEF7D9D82</gtr:id><gtr:title>The Catalytic Mechanism of a Natural Diels-Alderase Revealed in Molecular Detail.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe9ce646314a800e48225d08d9d5a42b"><gtr:id>fe9ce646314a800e48225d08d9d5a42b</gtr:id><gtr:otherNames>Byrne MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>58c2e766b0ae24.02983341</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D647DB9-B82B-4ECB-8046-DC242E58D574</gtr:id><gtr:title>Identification of the quinolinedione inhibitor binding site in Cdc25 phosphatase B through docking and molecular dynamics simulations.</gtr:title><gtr:parentPublicationTitle>Journal of computer-aided molecular design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/077fb9887ae91fe59e912d524a64bb93"><gtr:id>077fb9887ae91fe59e912d524a64bb93</gtr:id><gtr:otherNames>Ge Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0920-654X</gtr:issn><gtr:outcomeId>5a2fee71bc8376.68971505</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B2D7BF9-3A81-4434-A6CA-BC7F0DF2F852</gtr:id><gtr:title>The basis for carbapenem hydrolysis by class A &amp;Icirc;&amp;sup2;-lactamases: a combined investigation using crystallography and simulations.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a72568245f3eb5d96b7b1672aeb34ebc"><gtr:id>a72568245f3eb5d96b7b1672aeb34ebc</gtr:id><gtr:otherNames>Fonseca F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>54561516e44ba6.83242073</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1E31F75-48A1-483A-9324-B2838062D32F</gtr:id><gtr:title>QM/MM free-energy simulations of reaction in Serratia marcescens Chitinase B reveal the protonation state of Asp142 and the critical role of Tyr214.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry. B</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6b38b41bf18c53065e665984335faf4"><gtr:id>a6b38b41bf18c53065e665984335faf4</gtr:id><gtr:otherNames>Jitonnom J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1520-5207</gtr:issn><gtr:outcomeId>54561c75ef0d05.26678906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14900D3D-9A0A-4551-8835-2D1D86494A89</gtr:id><gtr:title>QM/MM Modelling of Drug-Metabolizing Enzymes</gtr:title><gtr:parentPublicationTitle>Current Topics in Medicinal Chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5a3bb9ff0e69b0.26646206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F57668F-F1BF-4747-BE96-6F2035BC63D0</gtr:id><gtr:title>Unraveling the role of protein dynamics in dihydrofolate reductase catalysis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/137e2978331d9bacd2bf41d6b654c949"><gtr:id>137e2978331d9bacd2bf41d6b654c949</gtr:id><gtr:otherNames>Luk LY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5675d8e711804</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BCD144A-724E-4AB2-AEFD-56C24E40E254</gtr:id><gtr:title>Quantum mechanics/molecular mechanics modeling of regioselectivity of drug metabolism in cytochrome P450 2C9.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>545615166f11c5.14144144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0780AEE-ADED-49E7-BDFD-60C071AA853D</gtr:id><gtr:title>Iron-Containing Enzymes - Versatile Catalysts of Hydroxylation Reactions in Nature</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:isbn>978-1-84973-181-2</gtr:isbn><gtr:outcomeId>545618de6a5c70.61611732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F59E7E54-2658-48B7-82F3-5659B0F8292C</gtr:id><gtr:title>Trends in predicted chemoselectivity of cytochrome P450 oxidation: B3LYP barrier heights for epoxidation and hydroxylation reactions.</gtr:title><gtr:parentPublicationTitle>Journal of molecular graphics &amp; modelling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/159e6d58a9d0758bf0066f354ce492ce"><gtr:id>159e6d58a9d0758bf0066f354ce492ce</gtr:id><gtr:otherNames>Rydberg P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1093-3263</gtr:issn><gtr:outcomeId>5456151568bfc1.87992643</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F22C7084-2FDF-4BF2-8A23-592177249EC6</gtr:id><gtr:title>Conformational change and ligand binding in the aristolochene synthase catalytic cycle.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fddacbc6ce8fb11a5bf667abf1aa4721"><gtr:id>fddacbc6ce8fb11a5bf667abf1aa4721</gtr:id><gtr:otherNames>van der Kamp MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>545615161c4578.73794089</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DDE3895-8E3E-4ABC-966C-DFDDF9CDB30F</gtr:id><gtr:title>Rapid decomposition and visualisation of protein-ligand binding free energies by residue and by water.</gtr:title><gtr:parentPublicationTitle>Faraday discussions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cfc092ebabd10e7bab211677c638b22"><gtr:id>0cfc092ebabd10e7bab211677c638b22</gtr:id><gtr:otherNames>Woods CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1359-6640</gtr:issn><gtr:outcomeId>54561514e4acf6.33507572</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A55C6990-F198-4411-8556-B67729AE7668</gtr:id><gtr:title>High level QM/MM modeling of the formation of the tetrahedral intermediate in the acylation of wild type and K73A mutant TEM-1 class A beta-lactamase.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry. A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ae927807f41e700cb21b0213afe5aaa"><gtr:id>5ae927807f41e700cb21b0213afe5aaa</gtr:id><gtr:otherNames>Hermann JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1089-5639</gtr:issn><gtr:outcomeId>5456165ce581a5.12425501</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>704244B9-28F7-406D-8392-22A152DF89EE</gtr:id><gtr:title>Modeling protein splicing: reaction pathway for C-terminal splice and intein scission.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry. B</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cace1a5b287fc5df940d4b2061a68dd4"><gtr:id>cace1a5b287fc5df940d4b2061a68dd4</gtr:id><gtr:otherNames>Mujika JI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1520-5207</gtr:issn><gtr:outcomeId>5456165d197913.20421204</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E45D355C-34AB-46C0-A22D-CF2DB47D066D</gtr:id><gtr:title>Computational assay of H7N9 influenza neuraminidase reveals R292K mutation reduces drug binding affinity.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cfc092ebabd10e7bab211677c638b22"><gtr:id>0cfc092ebabd10e7bab211677c638b22</gtr:id><gtr:otherNames>Woods CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>54561515b95ae7.05205198</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC13D383-D286-4ABD-B4AA-A8A463D7D419</gtr:id><gtr:title>A water-swap reaction coordinate for the calculation of absolute protein-ligand binding free energies.</gtr:title><gtr:parentPublicationTitle>The Journal of chemical physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cfc092ebabd10e7bab211677c638b22"><gtr:id>0cfc092ebabd10e7bab211677c638b22</gtr:id><gtr:otherNames>Woods CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9606</gtr:issn><gtr:outcomeId>5456165c6a9220.41858515</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12DFD7E0-8453-40A5-8909-6D90E9B1F93E</gtr:id><gtr:title>Quantum Mechanics/Molecular Mechanics Simulations Identify the Ring-Opening Mechanism of Creatininase.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6b38b41bf18c53065e665984335faf4"><gtr:id>a6b38b41bf18c53065e665984335faf4</gtr:id><gtr:otherNames>Jitonnom J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>5a352bc2ed67e4.97805619</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FA69C16-CBDC-4F89-A3C4-7DD2E90DF9D6</gtr:id><gtr:title>Insights into the Mechanistic Basis of Plasmid-Mediated Colistin Resistance from Crystal Structures of the Catalytic Domain of MCR-1.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/befc58d95b309466ced570b65ae0e450"><gtr:id>befc58d95b309466ced570b65ae0e450</gtr:id><gtr:otherNames>Hinchliffe P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c2e7664a3252.07231461</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>507D8124-CA81-493B-90C3-7E00316EE41E</gtr:id><gtr:title>Comparison of ab Initio, DFT, and Semiempirical QM/MM Approaches for Description of Catalytic Mechanism of Hairpin Ribozyme.</gtr:title><gtr:parentPublicationTitle>Journal of chemical theory and computation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3fe2d5924ec77afc3c77004488de6bb"><gtr:id>e3fe2d5924ec77afc3c77004488de6bb</gtr:id><gtr:otherNames>Ml?nsk? V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1549-9618</gtr:issn><gtr:outcomeId>5675ecc70664b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49DFB6F4-88D1-4789-9DA1-952561C0DAAB</gtr:id><gtr:title>QM/MM modelling of ketosteroid isomerase reactivity indicates that active site closure is integral to catalysis.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fddacbc6ce8fb11a5bf667abf1aa4721"><gtr:id>fddacbc6ce8fb11a5bf667abf1aa4721</gtr:id><gtr:otherNames>van der Kamp MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>54561516bd7f95.97597782</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09C5F688-7839-40FF-B9A8-54E6C386A792</gtr:id><gtr:title>Ab Initio QM/MM Modeling of the Rate-Limiting Proton Transfer Step in the Deamination of Tryptamine by Aromatic Amine Dehydrogenase.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry. B</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/421a2ab4d7ba0423131ef31345d5075a"><gtr:id>421a2ab4d7ba0423131ef31345d5075a</gtr:id><gtr:otherNames>Ranaghan KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1520-5207</gtr:issn><gtr:outcomeId>5a2fedcd216269.51505815</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB8F6E04-C663-4367-BA5A-2DC473ECC223</gtr:id><gtr:title>Large-Scale Density Functional Theory Transition State Searching in Enzymes.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/879f80570b661acf297c717ba4b1fe71"><gtr:id>879f80570b661acf297c717ba4b1fe71</gtr:id><gtr:otherNames>Lever G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1948-7185</gtr:issn><gtr:outcomeId>54561c75c7af51.73494715</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED3159C3-8C30-4A0B-8A48-3237A78A8ED8</gtr:id><gtr:title>Quantum mechanics/molecular mechanics modeling of substrate-assisted catalysis in family 18 chitinases: conformational changes and the role of Asp142 in catalysis in ChiB.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6b38b41bf18c53065e665984335faf4"><gtr:id>a6b38b41bf18c53065e665984335faf4</gtr:id><gtr:otherNames>Jitonnom J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>54561c76bcd361.39975213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AA5FD23-AF5C-40F9-B43A-4E2BABA9EFB1</gtr:id><gtr:title>Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cfc092ebabd10e7bab211677c638b22"><gtr:id>0cfc092ebabd10e7bab211677c638b22</gtr:id><gtr:otherNames>Woods CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>5456151740ed82.61901817</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41DC858F-65A5-455C-AD78-73A6BFE51EE9</gtr:id><gtr:title>Understanding the determinants of selectivity in drug metabolism through modeling of dextromethorphan oxidation by cytochrome P450.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbe41a4cb5a07d73b26cc55382a5237b"><gtr:id>bbe41a4cb5a07d73b26cc55382a5237b</gtr:id><gtr:otherNames>Ol?h J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5456165c463413.26084657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0E6A56C-7034-46EF-98A9-44ACA01287DD</gtr:id><gtr:title>Multiscale analysis of enantioselectivity in enzyme-catalysed 'lethal synthesis' using projector-based embedding</gtr:title><gtr:parentPublicationTitle>Royal Society Open Science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0d10ae0b5fee7f7d7a790e1b961f1e4"><gtr:id>f0d10ae0b5fee7f7d7a790e1b961f1e4</gtr:id><gtr:otherNames>Zhang X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5a981e74db7333.01343390</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>596C83F6-421D-46E5-A372-2B5B70994D13</gtr:id><gtr:title>Mechanism of C-terminal intein cleavage in protein splicing from QM/MM molecular dynamics simulations.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cace1a5b287fc5df940d4b2061a68dd4"><gtr:id>cace1a5b287fc5df940d4b2061a68dd4</gtr:id><gtr:otherNames>Mujika JI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>545618de427bf0.93869040</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFE8AF07-5E33-469D-A787-BBA69A802E0D</gtr:id><gtr:title>A catalytic role for methionine revealed by a combination of computation and experiments on phosphite dehydrogenase</gtr:title><gtr:parentPublicationTitle>Chem. Sci.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3972a2fe576f5ce5a419b9f38af99e1"><gtr:id>d3972a2fe576f5ce5a419b9f38af99e1</gtr:id><gtr:otherNames>Ranaghan K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545618dde15a16.85432659</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6ECF4FD-C43A-4446-9F2B-D156AC1596C4</gtr:id><gtr:title>Structural Fluctuations in Enzyme-Catalyzed Reactions: Determinants of Reactivity in Fatty Acid Amide Hydrolase from Multivariate Statistical Analysis of Quantum Mechanics/Molecular Mechanics Paths.</gtr:title><gtr:parentPublicationTitle>Journal of chemical theory and computation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dae4f96b4cfddf91a29835a6fb7a9371"><gtr:id>dae4f96b4cfddf91a29835a6fb7a9371</gtr:id><gtr:otherNames>Lodola A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1549-9618</gtr:issn><gtr:outcomeId>54561c7712acc3.89603649</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B8BAF8A-F7E4-446F-A298-418C1D81F499</gtr:id><gtr:title>Insights into the mechanism and inhibition of fatty acid amide hydrolase from quantum mechanics/molecular mechanics (QM/MM) modelling.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dae4f96b4cfddf91a29835a6fb7a9371"><gtr:id>dae4f96b4cfddf91a29835a6fb7a9371</gtr:id><gtr:otherNames>Lodola A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>doi_53d030030c5c5646</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63F06E41-C197-4773-98B9-C7707D68DB15</gtr:id><gtr:title>Optimal control design of laser pulses for mode specific vibrational excitation in an enzyme-substrate complex</gtr:title><gtr:parentPublicationTitle>Chemical Physics Letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fae3fb636620fa73f3f1d85f2ddb17d3"><gtr:id>fae3fb636620fa73f3f1d85f2ddb17d3</gtr:id><gtr:otherNames>Ren Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>doi_53cfebfeb3c0a2fc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE3AD6AD-F38D-4564-9240-8C27F8525469</gtr:id><gtr:title>Conformational effects on the pro-S hydrogen abstraction reaction in cyclooxygenase-1: an integrated QM/MM and MD study.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/771e813ec673acf96f31bcf62753f443"><gtr:id>771e813ec673acf96f31bcf62753f443</gtr:id><gtr:otherNames>Christov CZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>5675d82130593</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36A6BD8D-7A29-4C58-B5BE-2A4982BA7CA5</gtr:id><gtr:title>Structure and Function in Homodimeric Enzymes: Simulations of Cooperative and Independent Functional Motions.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80aef585e94cf6d5924ff590e3804d8a"><gtr:id>80aef585e94cf6d5924ff590e3804d8a</gtr:id><gtr:otherNames>Wells SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5675e9ccd3f58</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D8BAC6C-02BC-4984-A2EB-A2E9E6FB82A3</gtr:id><gtr:title>Quantum Mechanics/Molecular Mechanics Modeling of Drug Metabolism: Mexiletine N-Hydroxylation by Cytochrome P450 1A2.</gtr:title><gtr:parentPublicationTitle>Chemical research in toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0893-228X</gtr:issn><gtr:outcomeId>585d71bab0c709.03180808</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51A595D8-8118-4DE1-8620-FC420D7610E7</gtr:id><gtr:title>Does compound I vary significantly between isoforms of cytochrome P450?</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>545615181452e7.52176042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BF4E287-05B4-40C7-97E5-9DD956C98D78</gtr:id><gtr:title>Biomolecular simulation and modelling: status, progress and prospects.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fddacbc6ce8fb11a5bf667abf1aa4721"><gtr:id>fddacbc6ce8fb11a5bf667abf1aa4721</gtr:id><gtr:otherNames>van der Kamp MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn><gtr:outcomeId>585d4afd710375.62350529</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3F8A859-CAE7-43A0-8C99-E09BCD208A80</gtr:id><gtr:title>Taking Ockham's razor to enzyme dynamics and catalysis.</gtr:title><gtr:parentPublicationTitle>Nature chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2d4ab7296ab4fb4689acfa0d1bce2aa"><gtr:id>e2d4ab7296ab4fb4689acfa0d1bce2aa</gtr:id><gtr:otherNames>Glowacki DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1755-4330</gtr:issn><gtr:outcomeId>54561517733ff6.13470518</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27E69774-C4B8-4D45-A60D-86F84E05F8A5</gtr:id><gtr:title>&amp;quot;Lethal Synthesis&amp;quot; of Fluorocitrate by Citrate Synthase Explained through QM/MM Modeling</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8057ee5f819b2e0a09f65247427fb63"><gtr:id>b8057ee5f819b2e0a09f65247427fb63</gtr:id><gtr:otherNames>van der Kamp M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>5675ed246b798</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D622506F-E271-4B76-9FC9-D7A49AFEEFD1</gtr:id><gtr:title>Reaction mechanism of N-acetylneuraminic acid lyase revealed by a combination of crystallography, QM/MM simulation, and mutagenesis.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5a1dac39946fe339bf47f488f607f3a"><gtr:id>f5a1dac39946fe339bf47f488f607f3a</gtr:id><gtr:otherNames>Daniels AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn><gtr:outcomeId>54561c76477486.92747382</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EC6D4BE-935F-4784-B1FD-3737BC1C10F5</gtr:id><gtr:title>Understanding the role of carbamate reactivity in fatty acid amide hydrolase inhibition by QM/MM mechanistic modelling.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dae4f96b4cfddf91a29835a6fb7a9371"><gtr:id>dae4f96b4cfddf91a29835a6fb7a9371</gtr:id><gtr:otherNames>Lodola A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>545618de959d92.04680636</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2514EDA3-84E2-46F6-B439-AA555AF68739</gtr:id><gtr:title>QM/MM modelling of drug-metabolizing enzymes.</gtr:title><gtr:parentPublicationTitle>Current topics in medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1568-0266</gtr:issn><gtr:outcomeId>545615158eb652.43969605</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D84D539-4A36-4D87-82A9-40B742F58A32</gtr:id><gtr:title>Analysis of chorismate mutase catalysis by QM/MM modelling of enzyme-catalysed and uncatalysed reactions.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8ecbf7aaf59f67fc44d18a72bd1de7f"><gtr:id>e8ecbf7aaf59f67fc44d18a72bd1de7f</gtr:id><gtr:otherNames>Claeyssens F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>56758e94dde18</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24592385-0A36-4B99-AA8D-EA9588F5BBE6</gtr:id><gtr:title>Quantum mechanics/molecular mechanics modeling of fatty acid amide hydrolase reactivation distinguishes substrate from irreversible covalent inhibitors.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dae4f96b4cfddf91a29835a6fb7a9371"><gtr:id>dae4f96b4cfddf91a29835a6fb7a9371</gtr:id><gtr:otherNames>Lodola A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>5675d8133ce66</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>976D35CF-9D41-4953-9B76-27C854CB8E96</gtr:id><gtr:title>Role of active site residues in promoting cobalt-carbon bond homolysis in adenosylcobalamin-dependent mutases revealed through experiment and computation.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/946dcf11ed80533ada0a6d42e3904c13"><gtr:id>946dcf11ed80533ada0a6d42e3904c13</gtr:id><gtr:otherNames>Rom?n-Mel?ndez GD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>54561c7671c472.11875429</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5E01785-4CC6-4E8C-9CD4-8188AF8F999A</gtr:id><gtr:title>Protein dynamics and enzyme catalysis: the ghost in the machine?</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2d4ab7296ab4fb4689acfa0d1bce2aa"><gtr:id>e2d4ab7296ab4fb4689acfa0d1bce2aa</gtr:id><gtr:otherNames>Glowacki DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>5456151716f811.95588088</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06EB6447-AE31-4E6D-9867-19F65D17FA7A</gtr:id><gtr:title>QM/MM modeling of benzene hydroxylation in human cytochrome P450 2C9.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry. A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2659373397704e50ec0a049ecd791e2"><gtr:id>a2659373397704e50ec0a049ecd791e2</gtr:id><gtr:otherNames>Bathelt CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1089-5639</gtr:issn><gtr:outcomeId>5456165dd19ea6.88869496</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>410D916A-573B-488C-942B-63C87BCCF824</gtr:id><gtr:title>Application of a SCC-DFTB QM/MM approach to the investigation of the catalytic mechanism of fatty acid amide hydrolase.</gtr:title><gtr:parentPublicationTitle>Journal of molecular modeling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c885855c3ce46c3561ab322d300c8fd"><gtr:id>6c885855c3ce46c3561ab322d300c8fd</gtr:id><gtr:otherNames>Capoferri L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0948-5023</gtr:issn><gtr:outcomeId>56758ec6c5011</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AD419BF-B31A-4406-918F-F28042DD3029</gtr:id><gtr:title>Biomolecular simulation: harnessing emerging technologies and embracing new communities</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d100cdc139a76b4405afb654a4ee30c3"><gtr:id>d100cdc139a76b4405afb654a4ee30c3</gtr:id><gtr:otherNames>Mulholland AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>545621f8b5dc80.84472835</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6738649-D1C1-4D65-90D1-13BD81D06363</gtr:id><gtr:title>Compound I reactivity defines alkene oxidation selectivity in cytochrome P450cam.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry. B</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1520-5207</gtr:issn><gtr:outcomeId>5456165cbc9875.41279240</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0528FF03-EA01-4E02-930F-9CA934A3D97E</gtr:id><gtr:title>Analysis and assay of oseltamivir-resistant mutants of influenza neuraminidase via direct observation of drug unbinding and rebinding in simulation.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cfc092ebabd10e7bab211677c638b22"><gtr:id>0cfc092ebabd10e7bab211677c638b22</gtr:id><gtr:otherNames>Woods CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>54561515e9d5e6.17594257</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EB47523-92DB-44C3-8C14-317B40547A45</gtr:id><gtr:title>Protein dynamics and enzyme catalysis: insights from simulations</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55403beb4008ead97ad897a869260f9f"><gtr:id>55403beb4008ead97ad897a869260f9f</gtr:id><gtr:otherNames>John David McGeagh</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>r_2219963304cac6d380</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26FFBDF6-87DA-402D-AD56-0C0E2C60F136</gtr:id><gtr:title>Combined quantum mechanics/molecular mechanics (QM/MM) methods in computational enzymology.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fddacbc6ce8fb11a5bf667abf1aa4721"><gtr:id>fddacbc6ce8fb11a5bf667abf1aa4721</gtr:id><gtr:otherNames>van der Kamp MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>5456151696e7c8.40642113</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7992C578-0009-4277-ADD0-50DC6A1DCCBB</gtr:id><gtr:title>Insights into conformational changes of procarboxypeptidase A and B from simulations: a plausible explanation for different intrinsic activity</gtr:title><gtr:parentPublicationTitle>Theoretical Chemistry Accounts</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6b38b41bf18c53065e665984335faf4"><gtr:id>a6b38b41bf18c53065e665984335faf4</gtr:id><gtr:otherNames>Jitonnom J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>doi_55f95c95cd5502e1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>180524E8-B96A-46D2-83D7-A4D82CB98B07</gtr:id><gtr:title>Comparison of DFT and ab initio QM/MM methods for modelling reaction in chorismate synthase</gtr:title><gtr:parentPublicationTitle>Chemical Physics Letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/844232136e686ecd5e21dcc2a3066a39"><gtr:id>844232136e686ecd5e21dcc2a3066a39</gtr:id><gtr:otherNames>Lawan N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5675ed236f967</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9E6FEE2-8B44-458A-BC75-1A9C02FC1B85</gtr:id><gtr:title>Effects of Dispersion in Density Functional Based Quantum Mechanical/Molecular Mechanical Calculations on Cytochrome P450 Catalyzed Reactions.</gtr:title><gtr:parentPublicationTitle>Journal of chemical theory and computation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a25c5b146e774a3fac75a721b566084"><gtr:id>4a25c5b146e774a3fac75a721b566084</gtr:id><gtr:otherNames>Lonsdale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1549-9618</gtr:issn><gtr:outcomeId>54561c7695e412.15359015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8B457AF-93C4-4477-9270-F7C09882B581</gtr:id><gtr:title>Computer simulations of quantum tunnelling in enzyme-catalysed hydrogen transfer reactions.</gtr:title><gtr:parentPublicationTitle>Interdisciplinary sciences, computational life sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/421a2ab4d7ba0423131ef31345d5075a"><gtr:id>421a2ab4d7ba0423131ef31345d5075a</gtr:id><gtr:otherNames>Ranaghan KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1867-1462</gtr:issn><gtr:outcomeId>56758de0cc83b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAAB1E06-B7A3-4E8E-95D3-8137D6635ADD</gtr:id><gtr:title>Protein dynamics and enzyme catalysis: insights from simulations.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a5c461280273c1e519c8e04c480ec5a"><gtr:id>1a5c461280273c1e519c8e04c480ec5a</gtr:id><gtr:otherNames>McGeagh JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>56758e7d046a0</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/G007705/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>B971A4E6-FF4B-45BC-96D6-1E289961490D</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Catalysis &amp; enzymology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>02567418-12CB-462E-9092-530C6E63B359</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Chemical Biology</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>